Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cntr. for Clinical and Basic Research, Ballerup
Recent findings in osteoporosis described
April 26th, 2005
Osteoporosis research advances have been reported from Denmark, the United Kingdom and France. Study 1: Effective doses of ibandronate don't affect postmenopausal women's risk of cardiovascular disease by altering vascular calcification, according to a study from Denmark. "Animal experiments revealed conflicting results as to the impact of bisphosphonate treatment on atherosclerosis and related vascular calcification. The effect of long-term treatment with clinical doses of bisphosphonates on aortic calcification (AC) in an 'at-risk' population of osteoporotic elderly women has not been assessed systematically," said Laszlo B. Tanko and colleagues,...
Source: Cardiovascular Business Week (2005-04-26)
|
